These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Prevalence of hyperprolactinemia in schizophrenic patients treated with conventional antipsychotic medications or risperidone. Kinon BJ; Gilmore JA; Liu H; Halbreich UM Psychoneuroendocrinology; 2003 Apr; 28 Suppl 2():55-68. PubMed ID: 12650681 [TBL] [Abstract][Full Text] [Related]
8. Threshold of Dopamine D2/3 Receptor Occupancy for Hyperprolactinemia in Older Patients With Schizophrenia. Iwata Y; Nakajima S; Caravaggio F; Suzuki T; Uchida H; Plitman E; Chung JK; Mar W; Gerretsen P; Pollock BG; Mulsant BH; Rajji TK; Mamo DC; Graff-Guerrero A J Clin Psychiatry; 2016 Dec; 77(12):e1557-e1563. PubMed ID: 28086010 [TBL] [Abstract][Full Text] [Related]
9. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020. Yıldız M; Osman E Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516 [TBL] [Abstract][Full Text] [Related]
10. Improvement in hyperprolactinemia and reproductive comorbidities in patients with schizophrenia switched from conventional antipsychotics or risperidone to olanzapine. Kinon BJ; Ahl J; Liu-Seifert H; Maguire GA Psychoneuroendocrinology; 2006 Jun; 31(5):577-88. PubMed ID: 16488084 [TBL] [Abstract][Full Text] [Related]
11. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance]. Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066 [TBL] [Abstract][Full Text] [Related]
13. Risperidone (depot) for schizophrenia. Sampson S; Hosalli P; Furtado VA; Davis JM Cochrane Database Syst Rev; 2016 Apr; 4(4):CD004161. PubMed ID: 27078222 [TBL] [Abstract][Full Text] [Related]
14. Olanzapine versus other atypical antipsychotics for schizophrenia. Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348 [TBL] [Abstract][Full Text] [Related]
15. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole. Lu ML; Shen WW; Chen CH Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860 [TBL] [Abstract][Full Text] [Related]
16. [Metabolic side effects of risperidone in early onset schizophrenia]. Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267 [TBL] [Abstract][Full Text] [Related]
17. Hyperprolactinemia and estimated dopamine D2 receptor occupancy in patients with schizophrenia: analysis of the CATIE data. Tsuboi T; Bies RR; Suzuki T; Mamo DC; Pollock BG; Graff-Guerrero A; Mimura M; Uchida H Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():178-82. PubMed ID: 23727135 [TBL] [Abstract][Full Text] [Related]
18. Gender-specific prolactin response to antipsychotic treatments with risperidone and olanzapine and its relationship to drug concentrations in patients with acutely exacerbated schizophrenia. Yasui-Furukori N; Saito M; Nakagami T; Sugawara N; Sato Y; Tsuchimine S; Furukori H; Kaneko S Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):537-40. PubMed ID: 20170699 [TBL] [Abstract][Full Text] [Related]
20. Effects of olanzapine on prolactin levels of female patients with schizophrenia treated with risperidone. Kim KS; Pae CU; Chae JH; Bahk WM; Jun TY; Kim DJ; Dickson RA J Clin Psychiatry; 2002 May; 63(5):408-13. PubMed ID: 12019665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]